PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)

PHASE3RecruitingINTERVENTIONAL
Enrollment

1,100

Participants

Timeline

Start Date

July 19, 2018

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Traumatic Brain Injury
Interventions
DRUG

Dalteparin

Dalteparin in prophylactic doses administered daily if screening criteria are satisfied.

DRUG

Saline

Saline in prophylactic doses administered daily if screening criteria are satisfied.

Trial Locations (12)

T2N 2T9

RECRUITING

Foothills Medical Centre, Calgary

T5H 3V9

RECRUITING

Royal Alexandra Hospital, Edmonton

T6G 2B7

RECRUITING

University of Alberta Hospital, Edmonton

V5Z 1M9

RECRUITING

Vancouver General Hospital, Vancouver

B3H 3A7

RECRUITING

Queen Elizabeth II Health Sciences Centre, Halifax

L8N 3Z5

RECRUITING

Hamilton Health Sciences Centre, Hamilton

K7N 2V7

RECRUITING

Kingston General Hospital, Kingston

KIH 8L6

RECRUITING

The Ottawa Hospital, Ottawa

M4N 3M5

RECRUITING

Sunnybrook Health Science Centre, Toronto

M5B1W8

RECRUITING

Unity Health Toronto, Toronto

G1J 1Z4

RECRUITING

Hopital de L'Enfant-Jesus, Québec

S7N 0W8

RECRUITING

Royal University Hospital, Saskatoon

All Listed Sponsors
collaborator

Sunnybrook Research Institute

OTHER

lead

Sunnybrook Health Sciences Centre

OTHER